In lung cancer, β-Ele adjuvant treatment could overcome the radioresistance of NSCLC and reverse the epithelial mesenchymal transition and cancer stem cells transdifferentiation induced by radiation via the Prx-1/NF-kB/iNOS pathway [25]. This evidence concerns the gene NFKB1 and lung cancer.